China Research (59)
59 papers in the China topic, indexed by PF-Atlas from PubMed and global journals.
- Pleura organoid transplantation facilitates visceral pleural repair through CD133 progenitor cell-mediated regeneration. · Experimental & molecular medicine · 2026
- Biomimetic dual-functional hydrogel for pulmonary injury repair: Enhancing sealing and tissue regeneration. · Biomaterials · 2026
- Buyang Huanwu Decoction Alleviates Bleomycin-Induced Pulmonary Fibrosis via Wnt/β-catenin and TGF-β1/Smad Pathways. · Chemistry & biodiversity · 2026
- [Research progress on TCM regulation of macrophage polarization for treatment of pulmonary diseases]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- Human Urine Stem Cells Alleviate Pulmonary Fibrosis via Inhibiting Macrophage-Myofibroblast Transition. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
- Treatment of pulmonary fibrosis: From disease mechanisms to future novel therapies . · International journal of molecular medicine · 2026
- Pulmonary fibrosis: Emerging targets and novel therapeutics. · The Journal of international medical research · 2026
- Shengxian decoction mitigate bleomycin-induced pulmonary fibrosis in mice via MerTK mediated macrophage efferocytosis. · Journal of ethnopharmacology · 2026
- Study on the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula by inhibiting M2 macrophage polarization and regulating TGF - β/SMAD signaling pathway. · Journal of ethnopharmacology · 2026
- Antimicrobial peptide LL37 ameliorated experimental inflammation induced neonatal lung injury through macrophage immunomodulation. · Pediatrics and neonatology · 2026
- Yizong Tongluo formula attenuates idiopathic pulmonary fibrosis and inflammatory injury by inhibiting HIF-1α/LSH/SCD1-mediated ferroptosis. · Frontiers in immunology · 2026
- NLRP3 Inflammasome Inhibition by Xuanfei Baidu Decoction Attenuates Pulmonary Inflammation and Collagen Deposition in Silicosis. · Pharmaceuticals (Basel, Switzerland) · 2026
- NRICM102, a TCM Formula, Attenuates COPD-Relevant Inflammatory Lung Injury in Mice by Improving Pulmonary Function and Reversing Immune Dysregulation. · Pharmaceuticals (Basel, Switzerland) · 2026
- Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. · Functional & integrative genomics · 2026
- Cortex Mori Radicis Mitigates Inflammation and Fibrosis in Pulmonary Fibrosis Through PI3K/AKT Pathway Suppression. · Canadian respiratory journal · 2026
- Multi-omics reveals the effects and mechanisms of Xinxue Granules against idiopathic pulmonary fibrosis through activating the cAMP/EPAC/CREB axis. · Journal of ethnopharmacology · 2026
- Targeting the fibrosis-inflammation-oxidative stress axis: multifaceted mechanisms of salidroside in chronic organ fibrosis. · Apoptosis : an international journal on programmed cell death · 2026
- The lysine-specific demethylase 1 inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study. · Blood advances · 2026
- Targeting alveolar type II cell dysfunction in idiopathic pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strategies . · International journal of molecular medicine · 2026
- [Ameliorative effects and mechanisms of Buyang Huanwu Decoction and its different ethanol elution fractions on pulmonary fibrosis model rats]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- [Investigating on mechanism of Yangyin Yifei Tongluo Pills in improving idiopathic pulmonary fibrosis based on bioinformatics and machine learning combined with UHPLC-Q Exactive Orbitrap-HRMS]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- [Maiwei Yangfei Decoction alleviates pulmonary fibrosis in mice by inhibiting cellular senescence via p53 signaling pathway]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- [Effect of Maxing Kugan Decoction on intestinal flora in bleomycin-induced idiopathic pulmonary fibrosis rats]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- Engineered mesenchymal stem cells regulate integrated stress response for fibrosis therapy. · Med (New York, N.Y.) · 2026
- Targeted depletion of activated fibroblasts via [ Lu]Lu-FAPI radionuclide therapy ameliorates bleomycin-induced lung fibrosis. · Frontiers in immunology · 2026
- Jinshui Liujun Decoction attenuates cigarette smoke-induced small airway remodeling via the TGF-β/Smad2/CFTR Axis. · The journal of physiological sciences : JPS · 2026
- WuYeLuGen Granule Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats by Inhibiting the TGF-β1/Smad Signaling Pathway and Epithelial-Mesenchymal Transition. · Canadian respiratory journal · 2026
- Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial-Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin-Induced Pulmonary Fibrogenesis. · Canadian respiratory journal · 2026
- Inhalable HUCMSC-Lipo biomimetic formulation inhibits fibroblast activation in mouse and non-human primate pulmonary fibrosis models. · Science bulletin · 2026
- Analysis of Prescription Medication Rules of Chinese Herbal Medicine for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Based on Data Mining. · Journal of visualized experiments : JoVE · 2026
- Airway administered artificial mitochondria-enriched nanovesicles for efficient and selective mitochondria transfer to intervene in pulmonary fibrosis. · Nature communications · 2026
- Preclinical Evidence and Mechanisms of Traditional Chinese Medicine Polysaccharides Regulating the Gut-Lung Axis via Gut Microbiota in Respiratory Diseases. · Nutrients · 2026
- Beyond Pathogens: Modulating the Commensal Microbiota to Reshape Immunity for Respiratory Disease Intervention. · Pathogens (Basel, Switzerland) · 2026
- How extracellular vesicles contribute to pulmonary fibrosis: miRNA-mediated mechanisms, diagnostic potential, and emerging therapeutic strategies. · Molecular biology reports · 2026
- Combined Network Pharmacology, Transcriptomics and Machine Learning Suggests Danggui Buxue Tang May Suppress Oxidative Stress and Inflammation through Nrf2/HO-1 and IL-17 Pathways in Pulmonary Fibrosis. · Journal of ethnopharmacology · 2026
- Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α-mediated glycolysis. · Frontiers in immunology · 2026
- Yupingfeng San extract ameliorates cisplatin induced renal interstitial fibrosis via IL-6/JAK/STAT3 mediated restoration of mitochondrial homeostasis. · Journal of ethnopharmacology · 2026
- The protective effects and material basis of Astragalus membranaceus in the prevention and treatment of radiation-induced lung injury via modulation of the Keap1-Nrf2 signaling pathway. · Journal of ethnopharmacology · 2026
- [Tibetan Medicine Classic Formula Srolo Bzhtang Granules Ameliorates Pulmonary Fibrosis via Dual Pathways of Nrf2/HO-1 and PI3K/AKT/mTOR Regulating Oxidative Stress]. · Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
- Treatment of pulmonary fibrosis and combined pulmonary fibrosis and emphysema syndrome with herbs for promoting blood circulation and removing blood stasis: A review of pharmacological studies. · Journal of ethnopharmacology · 2026
- Integrated Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics Reveal the Mechanisms and Active Constituents of Qingfei Huoxue Decoction Against Bleomycin-Induced Pulmonary Fibrosis. · Drug design, development and therapy · 2026
- Licochalcone A from Ma-Xing-Shi-Gan decoction to prevent Asthma through the inhibition of ferroptosis CD4+ T Cell by GART/HSP90α signaling pathway. · International immunopharmacology · 2026
- [Junren Bufei Yixin Granules attenuates hypoxic pulmonary hypertension via PTBP1/PKM2 signaling pathway]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
- Buyanghuanwu decoction attenuates hepatic fibrosis in CCl -induced mice by regulating bile acid metabolism through activating PPARα. · Journal of ethnopharmacology · 2026
- Huangqi Guizhi Wuwu Decoction attenuates bleomycin-induced pulmonary fibrosis via modulating TGF-β/Smad and cell-cycle: Integrated transcriptomics, network pharmacology and experimental validation. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- Fight Against Pulmonary Fibrosis: Integrating Mechanistic Insights and Innovative Therapies. · Current pharmaceutical biotechnology · 2026
- Biomimetic nanoparticles facilitating the functional engraftment of lung epithelial stem cells for silicosis therapy. · Journal of nanobiotechnology · 2026
- Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies. · Pediatric discovery · 2026
- Targeting immunosenescence in lung diseases: mechanistic insights and clinical interventions. · BMC medicine · 2026
- Restoring the FOXO1 geroprotective pathway via seno-resistant mesenchymal progenitor cells alleviates primate epididymal aging. · Protein & cell · 2026
- The Application and Challenges of Stem Cell-Derived Extracellular Vesicles in Inhalation Lung Injury. · International journal of nanomedicine · 2026
- Dual-Functional PDA@Au/CeO Nanozymes Enable CT Tracking and Potent Antifibrotic MSC Therapy. · ACS applied materials & interfaces · 2026
- How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications. · Analytical cellular pathology (Amsterdam) · 2026
- Stem cell-based therapies for silicosis: mechanisms, sources, clinical translation, and emerging strategies. · Frontiers in immunology · 2026
- Chronic graft-versus-host disease. · Nature reviews. Disease primers · 2026
- LingGui QiHua-3 decoction ameliorates cardiorenal dysfunction in HFpEF by restoring fluid homeostasis via the PCSK6/Corin/p38 MAPK/AQPs axis. · Journal of ethnopharmacology · 2026
- Activation of Sirt1 by Glyasperin F Suppresses PI3K/Akt/HIF-1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis-Associated Interstitial Lung Disease. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
- ZhuYang TongBi decoction ameliorates pulmonary fibrosis by degrading TGFBR via CAV1. · Fitoterapia · 2026
- Mesenchymal stem cell-derived microvesicles confer protection against rheumatoid arthritis-associated interstitial lung disease. · Stem cell research & therapy · 2026
Medical disclaimer. Research listings are for information only and are not medical advice.